Our Website Uses Cookies
We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.
For more information, please contact us or consult our Privacy Notice.
Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
Richard Kruger is a member of the firm’s corporate practice group and is resident in our New York office.
- Representation of the sponsor in connection with the formation of a $400 million buyout fund focused on small and middle-market companies across a select group of industries that was structured as a series LLC.
- Representation of the sponsor in connection with the formation of separate account partnerships that invest alongside sponsor’s funds.
- Representation of a fund-of-funds sponsor in connection with the secondary purchase of a portfolio of fund interests from a public pension plan.
- Representation of the investment adviser of a fund with respect to its secondary investments in multiple hedge fund side-pocket interests.
- Advised UCB S.A. in the acquisition of a majority interest in Meizler Biopharma, S.A., a Brazilian pharmaceutical company.
- Represented Snow Phipps Group in its acquisition of Service Champ, Inc.
- Represented The Goodyear Tire & Rubber Company in a €250 million offering of senior notes due 2019 by one of its European subsidiaries, a $500.0 million offering of mandatory convertible preferred stock and a $650.0 million registered exchange offer of senior notes due 2020 for senior notes due 2011.
- Represented Moelis & Company as financial advisor to Amgen, in its acquisition of Micromet, Inc.
- Represented Perella Weinberg Partners as financial advisor to the special committee of J.Crew in its sale to TPC and Leonard Green Partners.
- Represented Foros Securities LLC as financial advisor to the special committee of Interactive Data Corporation in its sale to Silver Lake Partners and Warburg Pincus LLC for $3.4 billion.
- Represented Gleacher & Company as financial advisor to CKx, Inc., in its acquisition by an affiliate of Apollo Global Management.
- Represented BofA Merrill Lynch, financial adviser to TomoTherapy Incorporated, in its sale to Accuray Incorporated for $277 million.
- Represented Medarex in its $2.4 billion merger with Bristol-Myers Squibb.
- Advised Trustmark on its sale of preferred stock and warrants to the U.S. Treasury as part of the Treasury Department's Capital Purchase Program.
Memberships and Affiliations
- New York City Bar, Member
Previous Experience
- Rockstar Games (2001-2005)
December 5, 2018, Covington Alert
Earlier this year Congress passed and President Trump signed the Foreign Investment Risk Review Modernization Act (“FIRRMA”), transformational legislation reforming the operations of the Committee on Foreign Investment in the United States (“CFIUS”).
Covington Advises Public Pension Capital on Partnership with Kramer Van Kirk Credit Strategies
May 15, 2015
WASHINGTON, DC, May 15, 2015 — Covington represented Public Pension Capital, LLC in the formation of a strategic partnership with and investment in Kramer Van Kirk Credit Strategies LP, a Chicago-based manager of collateralized loan obligations with more than $4 billion in assets under management. Public Pension Capital also acquired a stake in KVK Technology ...
Covington Lawyers Recognized by New York Super Lawyers
9/18/2013
NEW YORK, September 18, 2013 — New York Super Lawyers selected 36 Covington & Burling lawyers for its 2013 list of top legal talent. Super Lawyers selects no more than five percent of the total lawyers in the state based on peer review and the publication’s independent research. Twenty-three Covington lawyers were named New York Super Lawyers: • Martin ...
Covington Advises UCB in Brazil Acquisition
June 4, 2012
NEW YORK, June 4, 2012 — Covington advised UCB S.A. in the acquisition of a majority interest in Meizler Biopharma, S.A., a Brazilian pharmaceutical company that commercializes a portfolio of in-licensed specialty products. The transaction agreements foresee performance related milestone payments in the coming years as well as an option to purchase the ...
February 2, 2012
NEW YORK, February 2, 2012 — Covington & Burling represented Moelis & Company, financial advisor to Amgen, in its cash acquisition of Micromet, Inc. in a deal valued at approximately $1.16 billion. The acquisition, reported on Jan. 26, includes blinatumomab, a Bispecific T cell Engager antibody in Phase 2 clinical development for acute lymphoblastic leukemia. ...
5/10/2011
NEW YORK, May 10, 2011 — CKx, Inc., an owner of premium entertainment content, today announced that it has entered into a definitive merger agreement to be acquired by an affiliate of Apollo Global Management, a leading global alternative asset manager. Covington & Burling LLP advised Gleacher & Company, Inc., financial advisor to CKx, on the transaction. Under ...
April 21, 2011
NEW YORK, April 21, 2011 — The Goodyear Tire & Rubber Company has announced that it has amended and restated its European revolving credit facility and closed an offering of €250 million of 6 3/4 percent Senior Notes due 2019 by its European subsidiary, Goodyear Dunlop Tires Europe B.V. Changes to the European credit facility include the extension of the ...
April 6, 2011
NEW YORK, April 6, 2011 — Covington & Burling LLP represented The Goodyear Tire & Rubber Company in its $500 million registered underwritten offering of 5.875 percent Mandatory Convertible Preferred Stock, which closed on March 31, 2011. Goldman, Sachs & Co., J.P. Morgan Securities LLC, Citi and Credit Agricole Securities (USA) Inc. served as joint book-running ...
March 7, 2011
NEW YORK, March 7, 2011 — Covington & Burling LLP represented BofA Merrill Lynch, financial adviser to TomoTherapy Incorporated, in its sale to Accuray Incorporated for $277 million. Under terms of the agreement, TomoTherapy will be sold to Accuray for $4.80 per share in cash and Accuray stock. TomoTherapy is a creator of advanced radiation therapy solutions ...
February 15, 2011
NEW YORK, February 15, 2011 — Covington & Burling LLP represented Perella Weinberg Partners, as financial advisor to NYSE Euronext, in its merger with Deutsche Börse AG announced today, forming the premier global exchange group. Under the terms of the agreement, NYSE shareholders will own 40 percent of the newly merged company, and Deutsche Börse shareholders ...
Covington Advises Perella Weinberg on $3B J.Crew Deal
November 23, 2010
NEW YORK, November 23, 2010 — J.Crew Group, Inc. today announced that it has entered into a definitive agreement to be acquired by funds affiliated with TPG Capital and Leonard Green & Partners, L.P. Under the terms of the agreement, holders of the outstanding common shares of J.Crew will receive $43.50 per share in cash, or a total of approximately $3 billion. ...
May 4, 2010
NEW YORK, May 4, 2010 — Interactive Data Corporation (IDC), a provider of financial market data, analytics and related solutions, today announced that it has entered into a definitive agreement to be acquired by investment funds managed by Silver Lake Partners and Warburg Pincus LLC in a transaction with a total value of $3.4 billion. British publishing company ...
December 9, 2009
NEW YORK, December 9, 2009 — Trustmark Corporation completed on December 7, 2009 the issuance of 5.4 million shares of Common Stock, raising gross proceeds of $115 million, in a transaction underwritten by UBS and J.P. Morgan. Today Trustmark announced that it completed the redemption of $215 million of its Fixed Rate Cumulative Perpetual Preferred Stock, Series ...
7/22/2009
NEW YORK, NY, July 22, 2009 — Medarex and Bristol-Myers Squibb announced today that Bristol-Myers Squibb entered into an agreement for Bristol-Myers Squibb to acquire all of the outstanding stock and stock equivalents of Medarex for $16.00 in cash per share, or aggregate consideration of $2.4 billion. Covington & Burling LLP advised Medarex on the ...
- New York Super Lawyers, Business/Corporate "Rising Star" (2013)